JPH0140036B2 - - Google Patents

Info

Publication number
JPH0140036B2
JPH0140036B2 JP58061065A JP6106583A JPH0140036B2 JP H0140036 B2 JPH0140036 B2 JP H0140036B2 JP 58061065 A JP58061065 A JP 58061065A JP 6106583 A JP6106583 A JP 6106583A JP H0140036 B2 JPH0140036 B2 JP H0140036B2
Authority
JP
Japan
Prior art keywords
group
formula
atoms
compound
octadecyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP58061065A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58188891A (ja
Inventor
Shutadoraa Peetaa
Rotsukuhofu Osubaruto
Opitsutsu Hansuugeoruku
Sharaa Kurausu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of JPS58188891A publication Critical patent/JPS58188891A/ja
Publication of JPH0140036B2 publication Critical patent/JPH0140036B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
JP58061065A 1982-04-14 1983-04-08 Ｎ―グリコシルカルボキサミド誘導体、その製造方法及び該誘導体を含有する抗感染力強化剤 Granted JPS58188891A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3213650.1 1982-04-14
DE19823213650 DE3213650A1 (de) 1982-04-14 1982-04-14 N-glycosylierte carbonsaeureamid-derivate, verfahren zu ihrer herstellung sowie ihre verwendung zur beeinflussung der koerpereigenen abwehr

Publications (2)

Publication Number Publication Date
JPS58188891A JPS58188891A (ja) 1983-11-04
JPH0140036B2 true JPH0140036B2 (enExample) 1989-08-24

Family

ID=6160842

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58061065A Granted JPS58188891A (ja) 1982-04-14 1983-04-08 Ｎ―グリコシルカルボキサミド誘導体、その製造方法及び該誘導体を含有する抗感染力強化剤

Country Status (19)

Country Link
US (1) US4683222A (enExample)
EP (1) EP0091645B1 (enExample)
JP (1) JPS58188891A (enExample)
KR (1) KR920000312B1 (enExample)
AT (1) ATE25525T1 (enExample)
AU (1) AU561016B2 (enExample)
CA (1) CA1230594A (enExample)
DE (2) DE3213650A1 (enExample)
DK (1) DK162883A (enExample)
ES (1) ES521422A0 (enExample)
FI (1) FI75172C (enExample)
GR (1) GR78512B (enExample)
HU (1) HU194262B (enExample)
IE (1) IE55112B1 (enExample)
IL (1) IL68350A (enExample)
NO (1) NO157145C (enExample)
PH (1) PH25527A (enExample)
PT (1) PT76502B (enExample)
ZA (1) ZA832580B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3213650A1 (de) * 1982-04-14 1983-10-27 Bayer Ag, 5090 Leverkusen N-glycosylierte carbonsaeureamid-derivate, verfahren zu ihrer herstellung sowie ihre verwendung zur beeinflussung der koerpereigenen abwehr
DE3339694A1 (de) * 1983-11-03 1985-05-15 Bayer Ag, 5090 Leverkusen Verwendung n-glycosilierter carbonsaeureamid-derivate als wachstumsfoerderer in der tierernaehrung
DE3403495A1 (de) * 1983-11-23 1985-05-30 Bayer Ag, 5090 Leverkusen Phosphorylierte glycosylamide, -harnstoffe, -carbamate und -thiocarbamate, verfahren zu ihrer herstellung sowie ihre verwendung
DE3344257A1 (de) * 1983-12-07 1985-06-13 Bayer Ag, 5090 Leverkusen Substituierte o-acyl-glycosylamide, verfahren zu iherer herstellung sowie ihre verwendung
DE3346623A1 (de) * 1983-12-14 1985-07-04 Bayer Ag, 5090 Leverkusen N-glycosylierte harnstoffe, carbamate und thiocarbamate, verfahren zu ihrer herstellung sowie ihre verwendung
DE3347522A1 (de) * 1983-12-30 1985-07-11 Troponwerke GmbH & Co KG, 5000 Köln N-glycosylierte carbonsaeureamid-derivate als mittel bei der bekaempfung von erkrankungen des rheumatischen formenkreises
DE3410238A1 (de) * 1984-03-21 1985-10-03 Bayer Ag, 5090 Leverkusen Glycolipid-aehnliche substanzen in liposomenform
DE3508025A1 (de) * 1985-03-07 1986-09-11 Bayer Ag, 5090 Leverkusen Substituierte o-sulfonyl-glycosylamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3521994A1 (de) * 1985-06-20 1987-01-02 Bayer Ag N-(2-aminoacylamido-2-desoxy-hexosyl)-amide-, -carbamate und -harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3604681A1 (de) * 1986-02-14 1987-08-20 Bayer Ag Neue n-glycosylamidderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3812681A1 (de) * 1988-04-16 1989-11-02 Bayer Ag Substituierte n-glycosylamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US5476924A (en) * 1989-01-27 1995-12-19 Duke University Protecting group for acetals and methods of using the same in the activation of saccharides
FR2676739B1 (fr) * 1991-05-22 1996-10-11 Stepan Europe N-alkyl, n-acetylosylamines, leur procede de preparation et leurs utilisations notamment en tant qu'agents tensioactifs ou agents de solubilisation pour l'isolement de proteines membranaires.
US5362480A (en) * 1991-12-31 1994-11-08 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions containing amino sugars as antiplaque agents
US5455232A (en) * 1992-02-04 1995-10-03 Piljac; Goran Pharmaceutical preparation based on rhamnolipid
FR2709061B1 (fr) * 1993-08-17 1996-07-19 Ladislas Robert Utilisation d'oligosaccharides dans la prévention et le traitement du vieillissement des tissus.
AU7613694A (en) * 1993-08-30 1995-03-22 Bayer Aktiengesellschaft Glycosyl amides of 6-amino-6-deoxy sugars
DE4329094A1 (de) * 1993-08-30 1995-03-02 Bayer Ag (Glycosylamid)-uronsäure-derivate
DK0716658T3 (da) * 1993-08-30 1997-12-22 Bayer Ag Glycosylamider af 2-aminocylamino-2-desoxysukkerarter
AU4371996A (en) * 1994-12-16 1996-07-03 Alcon Laboratories, Inc. Ophthalmic formulations of substituted glycosides
US6290971B1 (en) * 1995-06-15 2001-09-18 Aventis Pasteur Limited Adjuvant compositions comprising a mineral salt and another immunostimulating compound
US5872111A (en) * 1997-05-19 1999-02-16 Lever Brothers Company, Division Of Conopco, Inc. Compositions comprising glycosylamide surfactants
US6670330B1 (en) * 2000-05-01 2003-12-30 Theodore J. Lampidis Cancer chemotherapy with 2-deoxy-D-glucose
JP3664401B2 (ja) * 2003-01-22 2005-06-29 独立行政法人科学技術振興機構 Ｎ−グリコシド型糖脂質及びこれから成る中空繊維状有機ナノチューブ
US20050008699A1 (en) * 2003-07-11 2005-01-13 Fred Wehling Effervescent glucosamine composition
PL1991266T3 (pl) 2006-01-26 2013-11-29 Zoetis Services Llc Nowe kompozycje adiuwantów glikolipidowych

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2808402A (en) * 1954-08-19 1957-10-01 Rohm & Haas Method for preparing nu-sorbitylcarbamates
DE1261861B (de) * 1963-08-22 1968-02-29 Dehydag Gmbh Verfahren zur Herstellung von Glycaminabkoemmlingen
FR2187324B1 (enExample) * 1972-06-14 1975-06-20 Rech Pharmaceut Sc
US4228274A (en) * 1976-09-28 1980-10-14 Merck & Co., Inc. 1-Substituted glycopyranosides
JPS5649396A (en) * 1979-09-28 1981-05-02 Dai Ichi Seiyaku Co Ltd Novel muramyldipeptide derivative
DE3213650A1 (de) * 1982-04-14 1983-10-27 Bayer Ag, 5090 Leverkusen N-glycosylierte carbonsaeureamid-derivate, verfahren zu ihrer herstellung sowie ihre verwendung zur beeinflussung der koerpereigenen abwehr

Also Published As

Publication number Publication date
FI75172B (fi) 1988-01-29
DK162883A (da) 1983-10-15
ES8402313A1 (es) 1984-01-16
ES521422A0 (es) 1984-01-16
EP0091645A1 (de) 1983-10-19
PH25527A (en) 1991-07-24
IL68350A0 (en) 1983-07-31
FI75172C (fi) 1988-05-09
DK162883D0 (da) 1983-04-13
AU561016B2 (en) 1987-04-30
PT76502B (en) 1985-12-10
ATE25525T1 (de) 1987-03-15
PT76502A (en) 1983-05-01
AU1261583A (en) 1983-10-20
JPS58188891A (ja) 1983-11-04
IL68350A (en) 1988-09-30
NO157145B (no) 1987-10-19
DE3369851D1 (en) 1987-04-02
US4683222A (en) 1987-07-28
KR920000312B1 (ko) 1992-01-11
FI831230A0 (fi) 1983-04-12
ZA832580B (en) 1984-01-25
HU194262B (en) 1988-01-28
EP0091645B1 (de) 1987-02-25
KR840004761A (ko) 1984-10-24
IE830840L (en) 1983-10-14
FI831230L (fi) 1983-10-15
NO157145C (no) 1988-01-27
CA1230594A (en) 1987-12-22
NO831163L (no) 1983-10-17
IE55112B1 (en) 1990-06-06
DE3213650A1 (de) 1983-10-27
GR78512B (enExample) 1984-09-27

Similar Documents

Publication Publication Date Title
JPH0140036B2 (enExample)
US20140323705A1 (en) Manufacture of lacto-n-tetraose
EP1551228B1 (en) Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases
DE69825271T2 (de) Aminoalkyl-glucosamin-phosphat-verbindungen und ihrer verwendung als adjuvanten und immunoeffektoren
US5580858A (en) Immunosuppressive and tolerogenic modified Lewisx compounds
US4710491A (en) N-glycosylated carboxylic acid derivatives as agents for combating rheumatic diseases
US20110245488A1 (en) Process for the synthesis of l-fucosyl di- or oligo-saccharides and novel 2,3,4 tribenzyl-fucosyl derivatives intermediates thereof
US4737488A (en) Immune system-stimulating N-glycosylated ureas and carbamates
US5874411A (en) Oligosaccharide glycosides having mammalian immunosuppresive and tolerogenic properties
US6867194B2 (en) Enzyme activated nitric oxide donors
KR860002110B1 (ko) 치환된 o-아실글리코실아미드류의 제조방법
US4699899A (en) Substituted O-sulphonyl-glycosylamides, processes for their preparation and their use as medicaments
EP0143385B1 (de) Phosphorylierte Glycosylamide, -harnstoffe, -carbamate und -thiocarbamate, Verfahren zu ihrer Herstellung sowie ihre Verwendung
JP2014510781A (ja) Ｎ置換マンノサミン誘導体、その調製方法及びその使用
CA2110707A1 (en) Immunosuppressive and tolerogenic oligosaccharide modified lewis x and lewis a compounds
US4631272A (en) N-acylated 1-alkylamino-1-deoxy-ketose derivatives, a process for their preparation and their use
JPS60139696A (ja) 置換されたｏ‐アシルグリコシドの製薬学的使用
JPS60149597A (ja) Ｎ‐グリコシル化ウレア類、カルバメート類及びチオカルバメート類
US20140303363A1 (en) Preparation and Use of Isolactosamine and Intermediates therefor
US20070219144A1 (en) Immunomodulatory saccharide compounds
EP3000820A1 (en) Synthetic vaccines against Streptococcus pneumoniae serotype 8
Cattaneo OLIGOSACCHARIDES AND MOLECULAR RECOGNITION